NCT03104569View on ClinicalTrials.gov

Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions
Cholangitis
Interventions
PROCEDURE

Injection of 37℃ contrast agent

Nonionic contrast agent is heated to 37℃ in a incubator when injection of contrast agent

Trial Locations (3)

300100

Tianjin Nankai Hospital, Tianjin

710061

The first affiliated hospital of Xi 'an jiaotong university, Xi'an

730000

The first hospital of Lanzhou university, Lanzhou

All Listed Sponsors
lead

Hepatopancreatobiliary Surgery Institute of Gansu Province

OTHER

NCT03104569 - Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma | Biotech Hunter | Biotech Hunter